Misonix Pursues 3-D Ultrasound-Based HIFU Via Sonora, Focus Surgery Deals
This article was originally published in The Gray Sheet
Executive Summary
Misonix' move to gain a controlling stake in Sonora Medical Systems for $1.35 mil. is driven in part by the firm's plan to leverage Sonora's 3-D ultrasound know-how with a high-intensity focused ultrasound (HIFU) device developed by Focus Surgery for treatment of benign prostatic hyperplasia and prostate cancer.